Insider · CIK 0001569077
Eric Weisblum
Files at SILO (Silo Pharma, Inc.). First filing Nov 20, 2023, latest Dec 16, 2025.
In brief
Eric Weisblum files SEC Form 4 as CEO, president and director at SILO (Silo Pharma, Inc.). Since Nov 20, 2023, Eric Weisblum has reported 13 open-market buys worth $38k and 0 open-market sells worth $0, the latest filed on Dec 16, 2025.
After Eric Weisblum's past buys, the stock trailed the S&P 500 by a median 15.9% over six months (n = 6), and 0% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $2,075 of SILO on Dec 15, 2025, filed Dec 16, 2025, scored 38 (weak). In the last 12 months: 3 buys worth $7,657 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SILO: Silo Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | SILObuy Silo Pharma, Inc. | $2,075 5,000 shares | +2% | +11% from low-80% from high | |
| 43Moderate | SILObuy Silo Pharma, Inc. | $735 2,000 shares | +1% | 0% from low-82% from high | |
| 46Moderate | SILObuy Silo Pharma, Inc. | $4,847 12,000 shares | +6% | +2% from low-79% from high | |
| 46Moderate | SILObuy Silo Pharma, Inc. | $4,329 10,000 shares | +5% | +4% from low-78% from high | |
| 30Weak | SILObuy Silo Pharma, Inc. | $2,097 2,500 shares | +1% | - | |
| 25Weak | SILObuy Silo Pharma, Inc. | $4,625 5,000 shares | +3% | - | |
| 28Weak | SILObuy Silo Pharma, Inc. | $1,137 700 shares | +0% | +23% from low-53% from high | |
| 28Weak | SILObuy Silo Pharma, Inc. | $1,668 1,100 shares | +1% | +15% from low-56% from high | |
| 38Weak | SILObuy Silo Pharma, Inc. | $1,376 1,000 shares | +1% | +7% from low-62% from high | |
| 33Weak | SILObuy Silo Pharma, Inc. | $3,100 2,000 shares | +1% | +22% from low-57% from high | |
| 28Weak | SILObuy Silo Pharma, Inc. | $1,117 650 shares | +0% | +39% from low-51% from high | |
| 33Weak | SILObuy Silo Pharma, Inc. | $6,948 4,350 shares | +3% | +25% from low-56% from high | |
| 28Weak | SILObuy Silo Pharma, Inc. | $4,235 2,900 shares | +2% | +15% from low-60% from high |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +2,500 | $0.41 | $1,025 | 214,432 | Dec 16, 2025 |
| Dec 15, 2025 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +2,500 | $0.42 | $1,050 | 216,932 | Dec 16, 2025 |
| Nov 20, 2025 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +1,000 | $0.37 | $370 | 210,932 | Nov 21, 2025 |
| Nov 21, 2025 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +1,000 | $0.37 | $365 | 211,932 | Nov 21, 2025 |
| Nov 18, 2025 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +7,500 | $0.40 | $3,025 | 205,432 | Nov 20, 2025 |
| Nov 19, 2025 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +4,500 | $0.41 | $1,823 | 209,932 | Nov 20, 2025 |
| May 27, 2025 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +10,000 | $0.43 | $4,329 | 197,932 | May 28, 2025 |
| May 23, 2025 | SILO Silo Pharma, Inc. | AGrant or award Options (right to buy)derivative | +200,000 | $0.00 | $0 | 387,932 | May 27, 2025 |
| Dec 13, 2024 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +2,500 | $0.84 | $2,097 | 187,932 | Dec 16, 2024 |
| Nov 20, 2024 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +2,500 | $0.95 | $2,375 | 182,932 | Nov 22, 2024 |
| Nov 22, 2024 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +2,500 | $0.90 | $2,250 | 185,432 | Nov 22, 2024 |
| Dec 19, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +500 | $1.63 | $815 | 169,724 | Dec 21, 2023 |
| Dec 20, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +200 | $1.61 | $322 | 169,924 | Dec 21, 2023 |
| Dec 14, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +200 | $1.50 | $300 | 168,324 | Dec 18, 2023 |
| Dec 15, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +900 | $1.52 | $1,368 | 169,224 | Dec 18, 2023 |
| Dec 5, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +600 | $1.39 | $834 | 167,724 | Dec 7, 2023 |
| Dec 6, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +76 | $1.34 | $102 | 167,800 | Dec 7, 2023 |
| Dec 7, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +324 | $1.36 | $441 | 168,124 | Dec 7, 2023 |
| Nov 29, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +1,000 | $1.57 | $1,570 | 166,124 | Nov 30, 2023 |
| Nov 30, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +1,000 | $1.53 | $1,530 | 167,124 | Nov 30, 2023 |
| Nov 22, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +400 | $1.68 | $672 | 164,874 | Nov 27, 2023 |
| Nov 27, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +250 | $1.78 | $445 | 165,124 | Nov 27, 2023 |
| Nov 20, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +4,050 | $1.60 | $6,480 | 164,174 | Nov 22, 2023 |
| Nov 21, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +300 | $1.56 | $468 | 164,474 | Nov 22, 2023 |
| Nov 16, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +1,100 | $1.33 | $1,463 | 158,324 | Nov 20, 2023 |
| Nov 17, 2023 | SILO Silo Pharma, Inc. | POpen-market purchase Common Stock | +1,800 | $1.54 | $2,772 | 160,124 | Nov 20, 2023 |
Questions about Eric Weisblum
Answered from the filings on this page, as of the latest one.
Is Eric Weisblum buying or selling?
In the last 12 months Eric Weisblum reported 3 open-market buys worth $7,657 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $2,075 of SILO on Dec 15, 2025. Grants, option exercises and tax withholding are not counted.
How did Eric Weisblum's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 15.9% over six months across 6 past buys, with 0% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Eric Weisblum file Form 4?
Eric Weisblum has filed Form 4 at SILO (Silo Pharma, Inc.) as CEO and President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.